Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A desirability of outcome ranking (DOOR) for periprosthetic joint infection - a Delphi analysis.
Johns BP, Dewar DC, Loewenthal MR, Manning LA, Atrey A, Atri N, Campbell DG, Dunbar M, Kandel C, Khoshbin A, Jones CW, Lora-Tamayo J, McDougall C, Moojen DJF, Mulford J, Paterson DL, Peel T, Solomon M, Young SW, Davis JS. Johns BP, et al. Among authors: dewar dc. J Bone Jt Infect. 2022 Nov 10;7(6):221-229. doi: 10.5194/jbji-7-221-2022. eCollection 2022. J Bone Jt Infect. 2022. PMID: 36420109 Free PMC article.
Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint.
Manning L, Metcalf S, Dymock M, Robinson O, Clark B, Nelson R, Paterson DL, Yates P, Loewenthal M, Dewar D, Huggan P, Davis JS; Australasian Society for Infectious Diseases Clinical Research Network. Manning L, et al. Int J Antimicrob Agents. 2022 Jul;60(1):106598. doi: 10.1016/j.ijantimicag.2022.106598. Epub 2022 May 6. Int J Antimicrob Agents. 2022. PMID: 35533791 Clinical Trial.
21 results